reference/35991367

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35991367

Outgoing Links

Predicate	Object
contentType	Randomized Controlled Trial\|Multicenter Study\|Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't
issn	0883-9441
pageRange	154294-
publicationName	Journal of Critical Care
startingPage	154294
bibliographicCitation	Hu XY, Zhang W, Wang D, Sun Y, Hu Z, Zang B, Feng Y, Wang H, Zhou J, Zhao Q, Liu H, Wang T, Jiang W, Wang CY, Jin C, Dong K, Chen S, Yao X, Hu P, Du B; China Critical Care Clinical Trials Group (CCCCTG). Safety, tolerability, pharmacokinetics, and efficacy of kukoamine B in patients with sepsis: A randomized phase IIa trial. J Crit Care. 2023 Aug;76():154294. doi: 10.1016/j.jcrc.2023.154294. PMID: 37116228.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c240b7583634ccd91adcd10c9ec4f9e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_432a57f0ce74ce9921f485cb1ea285b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_127fc743d2d1c87db791849c12109270 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c691493fd93fb9a6b0ad458330ec471b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2392f767b5b23f415092ce1f6dfb5379 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f77db648f71863d85316594321cb6ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d74926afd97f36b184b9b232a7b71912 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23b5335ae70563c575bac507a2fc5b76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed14a2f37e8f3362d6c71bd4e8740ba3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_212bb744d82e32d2bd8d99d99d55cc46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31b56676786dcc2f43467d5789f9162c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f861748c9dcd007f821d573baec251ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9d7de5210c387002f927311bd22a958 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27fe2a782ffd566e190e534b332c61fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26bd8d2813981f8c0acb7fe883cb1aff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a72ef7c0b8daeb82cbc20d33b1222ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7461b9610c023b01d0d000ce56281f6c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc40256e42bad94a979a9ee591078cef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44e829e2956ea783c11dc8cf42b31790
date	202308
identifier	https://doi.org/10.1016/j.jcrc.2023.154294 https://pubmed.ncbi.nlm.nih.gov/37116228
isPartOf	https://portal.issn.org/resource/ISSN/0883-9441 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2512
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety, tolerability, pharmacokinetics, and efficacy of kukoamine B in patients with sepsis: A randomized phase IIa trial
discusses	http://id.nlm.nih.gov/mesh/M0020288 http://id.nlm.nih.gov/mesh/M0022551 http://id.nlm.nih.gov/mesh/M0557225 http://id.nlm.nih.gov/mesh/M0003137
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018805Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014662Q000627 http://id.nlm.nih.gov/mesh/D013096Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D002109Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10346914 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10308

Total number of triples: 48.